Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy
- Butterworth, K. (Speaker)
Activity: Talk or presentation types › Oral presentation
Activity: Talk or presentation types › Oral presentation